830
Helvetica Chimica Acta – Vol. 94 (2011)
128;128.3; 128.5; 128.9; 129.1; 129.4; 129.7; 131; 131.3; 132.1; 133; 134.7; 136; 139.9; 142.3; 142.8; 146;
151.3; 159.8; 160.3; 176; 178.3; 179; 181. Anal. calc. for C40H26N4O3: C 78.67, H 4.29, N 9.17; found: C
78.60, H 4.24, N 9.10.
1’,11’-Dihydro-1’,3’-diphenylspiro[2H-acenaphthylene-1,4’-benzo[g]pyrazolo[3,4-b]quinoline]-
1
2,5’,10’-trione (8a). Powder. M.p. 252 – 2558. IR (KBr): 3205, 1718, 1670, 1607. H-NMR ((D6)DMSO):
6.16 – 8.12 (m, 20 arom. H); 10.05 (s, NH). 13C-NMR ((D6)DMSO): 55; 103.4; 117.4; 123.7; 124.9; 126.3;
126.5; 127.1; 127.9; 128.1; 128.4; 128.6; 129.2; 130; 130.4; 131; 132; 133.9; 138.6; 140.6; 146.5; 149.8; 179.8;
181.3; 203.9. Anal. calc. for C37H21N3O3: C 79.99, H 3.81, N 7.56; found: C 79.91, H 3.88, N 7.62.
5’,8’-Dihydro-1’-(4-nitrophenyl)-3’-phenylspiro[2H-acenaphthylene-1,4’-furo[3,4-b]pyrazolo[4,3-
e]pyridine]-2,7’(1’H)-dione (8e). Cream powder. M.p. 230 – 2328. IR (KBr): 3383, 1750, 1723. 1H-NMR
((D6)DMSO): 5.00 (s, CH2); 6.31 – 8.20 (m, 15 arom. H); 10.84 (s, NH); 10.81 (s, NH). 13C-NMR
((D6)DMSO): 52; 66.3; 99.9; 103.7; 121.8; 122.3; 124; 125.2; 125.7; 127.3; 128; 128.2; 128.8; 129.4; 130;
131.6; 132; 132.7; 139.9; 141.4; 142.8; 143.7; 146.3; 151.5; 159.8; 170.4; 203.9. Anal. calc. for C31H18N4O5: C
70.72, H 3.45, N 10.64; found: C 70.67, H 3.39, N 10.57.
REFERENCES
[1] R. V. A. Orru, M. de Greef, Synthesis 2003, 1471.
[2] S. L. Schreiber, Science 2000, 287, 1964.
´
[3] J. Zhu, H. Bienayme, ꢂMulticomponent Reactionsꢃ, Wiley-VCH, Weinheim, Germany, 2005.
[4] A. Dçmling, Chem. Rev. 2006, 106, 17.
[5] L. Weber, Curr. Med. Chem. 2002, 9, 2085.
[6] R. J. Sundberg, ꢂThe Chemistry of Indolesꢃ, Academic, New York, NY, 1996.
[7] K. C. Joshi, P. Chand, Pharmazie 1982, 37, 1.
[8] J. F. M. Da Silva, S. J. Garden, A. C. Pinto, J. Braz. Chem. Soc. 2001, 12, 273.
[9] A. H. Abdel-Rahman, E. M. Keshk, M. A. Hanna, Sh. M. El-Bady, Bioorg. Med. Chem. 2004, 12,
2483.
[10] T.-H. Kang, K. Matsumoto, M. Tohda, Y. Murakami, H. Takayama, M. Kitajima, N. Aimi, H.
Watanabe, Eur. J. Pharmacol. 2002, 444, 39.
[11] J. Ma, S. M. Hecht, Chem. Commun. 2004, 1190.
[12] S.-L. Zhu, S.-J. Ji, Y. Zhang, Tetrahedron 2007, 63, 9365.
[13] R. S. Kumar, S. Perumal, Terahedron Lett. 2007, 48, 7164.
[14] R. G. Redkin, L. A. Shemchuk, V. P. Chernykh, O. V. Shishkin, S. V. Shishkina, Tetrahedron 2007, 63,
11444.
[15] G. Shanthi, G. Subbulakshmi, P. T. Perumal, Tetrahedron 2007, 63, 2057.
[16] A. A. Mohammadi, M. Dabiri, H. Qaraat, Tetrahedron 2009, 65, 3804.
[17] S. Chandrasekhar, N. R. Reddy, S. S. Sultana, C. Narsihmulu, K. V. Reddy, Tetrahedron 2006, 62,
338; H. Li, B. Wang, L. Deng, J. Am. Chem. Soc. 2006, 128, 732.
[18] B. Alcaide, P. Almendros, A. Luna, M. R. Torres, J. Org. Chem. 2006, 71, 4818.
[19] J. M. Janey, Y. Hsiao, J. D. Armstrong III, J. Org. Chem. 2006, 71, 390.
[20] M. S. Rasalkar, M. K. Potdar, S. S. Mohile, M. M. Salunkhe, J. Mol. Catal. A: Chem. 2005, 235, 267.
[21] D. B. Ramachary, N. S. Chowdari, C. F. Barbas III, Angew. Chem. 2003, 115, 4365.
[22] H. A. Oskooie, E. Roomizadeh, M. M. Heravi, J. Chem. Res. 2006, 246.
[23] A. Kumar, R. A. Maurya, Tetrahedron 2007, 63, 1946; C.-L. Shi, D.-Q. Shi, S. H. Kim, Z.-B. Huang,
S.-J. Ji, M. Ji, Tetrahedron 2008, 64, 2425; C.-L. Shi, D.-Q. Shi, S. H. Kim, Z.-B. Huang, M. Ji, Aust. J.
Chem. 2008, 61, 547.
[24] A. Bazgir, Z. N. Tisseh, P. Mirzaei, Terahedron Lett. 2008, 49, 5165.
[25] K. Jadidi, R. Ghahremanzadeh, A. Bazgir, Tetrahedron 2009, 65, 2005.
[26] M. Dabiri, S. C. Azimi, H. R. Khavasi, A. Bazgir, Tetrahedron 2008, 64, 7307.
[27] K. Jadidi, R. Ghahremanzadeh, A. Bazgir, J. Comb. Chem. 2009, 11, 341.
[28] R. Ghahremanzadeh, M. Sayyafi, S. Ahadi, A. Bazgir, J. Comb. Chem. 2009, 11, 393.
Received August 14, 2010